CSBR:NASDAQ
Champions Oncology Inc
US$4.70
arrow_upward
+1.18%(+0.055) 1D
ኖቬም 13, 4:00:00 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4.57
High
US$4.70
Low
US$4.52
Mkt. cap
65.49 ሚ
Avg. vol.
8.16 ሺ
Volume
3.02 ሺ
52-wk high
US$8.31
52-wk low
US$4.52
EPS
-US$0.08
Beta
0.47
Shares outstanding
13.92 ሚ
No. of employees
217
Open
US$4.57
High
US$4.70
Low
US$4.52
Mkt. cap
65.49 ሚ
Avg. vol.
8.16 ሺ
Volume
3.02 ሺ
52-wk high
US$8.31
52-wk low
US$4.52
EPS
-US$0.08
Beta
0.47
Shares outstanding
13.92 ሚ
No. of employees
217
News stories
From web sources and news partners
The Motley Fool
·
ከ47 ደቂቃዎች በፊት
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
BigGo Finance
·
ከ6 ሰዓቶች በፊት
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
24/7 Wall St.
·
ከ3 ሰዓቶች በፊት
Gilead Beat the S&P 500 by More Than 25 Points in the Past Year, but $1,000 From a Decade Ago Is Still Worth Less Than $3,500
Traders Union
·
ከ3 ሰዓቶች በፊት
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ኒው ጄርዚ, ዩናይትድ ስቴትስ
SectorHealth Care
Industry-
Websitechampionsoncology.com